Immunoprotectivity of Salmonella enterica serovar Enteritidis virulence protein, InvH, against Salmonella typhi
Authors
Abstract:
Objective(s):Typhoid fever is a dreadful disease of a major threat to public health in developing countries. Vaccination with bacterial immunodominant components such as surface proteins may prove as a potent alternative to live attenuated vaccines. InvH, an important part of needle complex in type three secretion system (TTSS) plays important role in efficient bacterial adherence and entry into epithelial cells. Materials and Methods:In this work we used a 15 kDa recombinant InvH protein of Salmonella enteric serovar Enteritidis to provoke antibody production in mouse. The mice were immunized by recombinant InvH and challenged with Salmonella typhi. Histopathology of spleen and liver were studied. Results:The immunized mice showed a significant rise of antibody after the second booster. The immunization induced protection against high doses of S. typhi. The bacterial challenge with sera showed significant protection against challenge dose of 2×109 CFU. Immunized sera reacted with S. typhi markedly. Immunoreaction of bacterially infected sera and InvH protein was significantly higher than the control group. Bacterial loads of S. typhi in spleen was more than liver. Decreased bacterial load was evident in immunized mice after 7 days. Histological examination of the liver showed the immunized mice liver remained unaffected. Conclusion: Efficacy of the virulence protein, InvH, in inhibition of this phenomenon by active immunization was shown here. It may be concluded that InvH, as an antigen, can develop protection against S. typhi infections. InvH may be exploited in protective measures as well as a diagnostic tool in Salmonella infections.
similar resources
immunoprotectivity of salmonella enterica serovar enteritidis virulence protein, invh, against salmonella typhi
objective(s):typhoid fever is a dreadful disease of a major threat to public health in developing countries. vaccination with bacterial immunodominant components such as surface proteins may prove as a potent alternative to live attenuated vaccines. invh, an important part of needle complex in type three secretion system (ttss) plays important role in efficient bacterial adherence and entry int...
full textSalmonella enterica Serovar Enteritidis, Japan
To the Editor: Nontyphoidal sal-monellae are the important causative agents of foodborne diseases in Japan and other industrialized countries. Salmonella enterica serovar Enter-itidis has risen to the leading cause of infection among Salmonella spp. since 1989 (1). Emergence of drug-resistant S. Enteritidis has been rarely reported while S. Typhimurium, another serovar of major public health co...
full textGenotyping of Salmonella enterica serovar Typhi strains
Results Forty representative S. Typhi strains belonged to 4 sequence types (ST1, ST2, ST890, and ST892). The predominant S. Typhi genotype (31/40) was ST2 and it had a diverse geographic distribution. We discovered two novel STs – ST890 and ST892. M-CGH showed that 69 genes in these two novel STs were divergent from S. Typhi Ty2, which belongs to ST1. In addition, 5 representative Typhi strains...
full textThe genome of Salmonella enterica serovar Typhi.
The generation of complete genome sequences provides a blueprint that facilitates the genetic characterization of pathogens and their hosts. The genome of Salmonella enterica serovar Typhi (S. Typhi) harbors ~5 million base pairs encoding some 4000 genes, of which >200 are functionally inactive. Comparison of S. Typhi isolates from around the world indicates that they are highly related (clonal...
full textMy Resources
Journal title
volume 17 issue 8
pages 560- 565
publication date 2014-08-01
By following a journal you will be notified via email when a new issue of this journal is published.
Keywords
Hosted on Doprax cloud platform doprax.com
copyright © 2015-2023